Frazier Lifesciences Acquisition - Warrants (09/12/2025) Operating Income

The latest operating income for FLACW is $-5.1M as of September 2022. That compares with $-1M in the prior-year period — down 389.1% year over year. Investors often review this figure alongside Frazier Lifesciences Acquisition - Warrants (09/12/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, FLACW's operating income moved from $-1M to $-5.1M — a 389.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Frazier Lifesciences Acquisition - Warrants (09/12/2025)'s operating scale or balance-sheet position.

A operating income figure of $-5.1M for FLACW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FLACW's operating income ($-5.1M), review year-over-year change from $-1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.